Zooca

Zooca (formerly Calanus) develops sustainable marine-based nutritional ingredients from the copepod Calanus finmarchicus, including a patented oil rich in omega fatty acids ("third generation omega‑3") and a protein hydrolysate. Their products are marketed as dietary supplements for humans and feed ingredients for aquaculture/pets. Clinical studies have shown benefits such as improved glucose tolerance, reduced visceral fat accumulation, enhanced muscle function, improved insulin sensitivity, body composition improvements, anti-inflammatory effects, and increased endurance capacity. The company continues to invest in R&D with academic partners to expand its product range.